Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection- Findings from a Prospective, Randomized, Controlled, Multi-Centric Trial
https://www.medrxiv.org/content/10.1101/2021.07.26.21261119v1.full
Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma
https://pubmed.ncbi.nlm.nih.gov/33715160/
Intravenous immunoglobulin therapy for COVID-19 ARDS
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00450-1/fulltext
Anti-SARS-CoV-2 hyperimmune globulin demonstrates potent neutralization and antibody-dependent cellular cytotoxicity and phagocytosis through N and S proteins
https://pubmed.ncbi.nlm.nih.gov/34693968/
RUSSIA 🇷🇺